
    
      Participants were inducted on either liquid or tablet buprenorphine, in a double-blind,
      double-dummy manner. They each reached a steady state by the second week, and were scheduled
      to have blood draws in weeks 3, 4, 7, 8, 11, 12, 15, and 16.
    
  